Repligen Corporation (RGEN) earnings
RGEN earnings moved a median of +0.09% by the close. Quarterly and annual RGEN reports and results, each read against the price at its own news timestamp. Back to the RGEN overview →
37 measured RGEN earnings events.
Where these RGEN earnings landedvs 36 measured RGEN earnings reactions
| Middle 50% of RGEN earnings reactions | -0.52% to +2.06% |
|---|---|
| Median reaction (to close) | +0.09% |
| Measured reactions | 36 |
Point-in-time · zero look-ahead
Half of the 36 RGEN earnings events with a measured close landed between -0.52% and +2.06%; 58% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Repligen to Report Third Quarter 2026 Financial Results | Press release | -0.30% | +1.69% | |
| Form 10-Q REPLIGEN CORP For: Jun 30 | SEC filing · Form 10-Q | -0.99% | -0.05% | |
| Repligen Reports Second Quarter 2026 Financial Results and Updates Full Year 2026 Financial Guidance | Press release | +2.69% | +4.04% | |
| Repligen to Report Second Quarter 2026 Financial Results | Press release | -0.12% | +0.25% | |
| Form 10-Q REPLIGEN CORP For: Mar 31 | SEC filing · Form 10-Q | -0.76% | -0.49% | |
| Repligen Reports First Quarter 2026 Financial Results and Updates Full Year 2026 Financial Guidance | Press release | +4.07% | +4.14% | |
| Repligen to Report First Quarter 2026 Financial Results | Press release | +0.22% | -7.22% | |
| Form 10-K REPLIGEN CORP For: Dec 31 | SEC filing · Form 10-K | -0.04% | -3.00% | |
| Form 10-Q REPLIGEN CORP For: Sep 30 | SEC filing · Form 10-Q | -0.18% | -0.39% | |
| Repligen Reports Third Quarter 2025 Financial Results and Updates Full Year 2025 Financial Guidance | Press release | -2.01% | -8.14% | |
| Repligen to Report Third Quarter 2025 Financial Results | Press release | +0.19% | +0.49% | |
| Form 10-Q REPLIGEN CORP For: Jun 30 | SEC filing · Form 10-Q | -1.25% | -2.11% | |
| Repligen Reports Second Quarter 2025 Financial Results and Updates Full Year 2025 Financial Guidance | Press release | +1.29% | — | |
| Repligen to Report Second Quarter 2025 Financial Results | Press release | +2.38% | +1.67% | |
| Form 10-Q REPLIGEN CORP For: Mar 31 | SEC filing · Form 10-Q | -1.16% | -1.11% | |
| Repligen Reports First Quarter 2025 Financial Results | Press release | -0.90% | +3.17% | |
| Repligen to Report First Quarter 2025 Financial Results | Press release | +1.07% | +0.46% | |
| Form 10-K REPLIGEN CORP For: Dec 31 | SEC filing · Form 10-K | -0.79% | +4.66% | |
| Form NT 10-K REPLIGEN CORP For: Dec 31 | SEC filing · Form NT | -0.52% | +0.78% | |
| Form 10-K/A REPLIGEN CORP For: Dec 31 | SEC filing · Form 10-K | +0.02% | +0.07% | |
| Form 10-Q REPLIGEN CORP For: Sep 30 | SEC filing · Form 10-Q | -0.08% | +0.10% | |
| Form 10-Q/A REPLIGEN CORP For: Jun 30 | SEC filing · Form 10-Q | -0.13% | +0.01% | |
| Form 10-Q/A REPLIGEN CORP For: Mar 31 | SEC filing · Form 10-Q | -0.19% | -0.05% | |
| Form 10-Q/A REPLIGEN CORP For: Sep 30 | SEC filing · Form 10-Q | -0.03% | +0.07% | |
| Form NT 10-Q REPLIGEN CORP For: Sep 30 | SEC filing · Form NT | +1.87% | +3.80% | |
| Repligen Reports Third Quarter 2024 Financial Results | Press release | +0.66% | +0.74% | |
| Repligen to Report Third Quarter 2024 Financial Results | Press release | +0.00% | -0.60% | |
| Form 10-Q REPLIGEN CORP For: Jun 30 | SEC filing · Form 10-Q | +0.28% | +3.96% | |
| Repligen Reports Second Quarter 2024 Financial Results | Press release | -0.03% | +5.18% | |
| Repligen to Report Second Quarter 2024 Financial Results | Press release | -0.45% | +8.63% | |
| Form 10-Q REPLIGEN CORP For: Mar 31 | SEC filing · Form 10-Q | -0.98% | +3.55% | |
| Repligen Reports First Quarter 2024 Financial Results | Press release | +1.48% | -0.40% | |
| Repligen to Report First Quarter 2024 Financial Results | Press release | -0.34% | -2.57% | |
| Form 10-K REPLIGEN CORP For: Dec 31 | SEC filing · Form 10-K | +0.30% | +0.57% | |
| Form 10-Q REPLIGEN CORP For: Sep 30 | SEC filing · Form 10-Q | +0.98% | -1.10% | |
| Repligen Reports Third Quarter 2023 Financial Results and Updates Full Year 2023 Financial Guidance | Press release | -1.02% | -0.07% | |
| Repligen to Report Third Quarter 2023 Financial Results | Press release | -2.07% | -2.25% |
Keep exploring
More RGEN: analyst actions → · SEC filings → · RGEN overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| The Cooper Companies, Inc. (COO) | 303 | -0.21% | 41% |
| PETVIVO HOLDINGS INC (PETV) | 302 | 0.00% | 40% |
| EIDOS THERAPEUTICS (EIDX) | 300 | +0.01% | 51% |
| Grifols, S.A. - American Depositary Shares (GRFS) | 300 | -0.13% | 39% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.